AP-1067

N/A

Report date: 2024/12/18 13:39:48

NME

Base Information

Drug NameAP-1067

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 2 (5-HT2) receptor antagonistsVoltage-gated calcium channel blockers

TargetsSerotonin 2 (5-HT2) receptorVoltage-gated calcium channel

Therapy Area/IndicationsHypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAjinomoto Co Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAjinomoto Co Inc

Active IndicationsN/A

Inactive IndicationsHypertension

ATC CodeN/A